Changes in Ownership

Alaunos Therapeutics, Inc. Filed 2013-10-31 Acc 0001140361-13-040086

Director bought 2,857,143 shares at $3.50 ($10,000,001)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
KIRK RANDAL J Director	2013-10-29	Purchase	+2,857,143	$3.50	$10,000,001	16,390,305	I
Open-market purchases · 2,857,143 sh · avg $3.50 · $10,000,001